apitegromab tirzepatide Scholar Rock (SRRK): High-Stakes Biotech With a Promising Pipeline—But a Pricey Premise Apitegromab Myostatin Inhibitor For Muscle
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5






















